Policy brief cover- Malawi national action plan on antimicrobial resistance: review of progress in the human health sector

Antimicrobial resistance (AMR) is a significant danger to modern medicine and public health. Sub-Saharan Africa bore the heaviest impact of the projected 1.27 million deaths that were directly linked to bacterial AMR in 2019.  OHT and WHO (World Health Organization) analysis of the AMR data that is currently available, with a focus on Malawi, indicates that resistance of common pathogens to many antimicrobials has grown since the early 2000s. The Malawian government has identified this problem and has gathered resources to mitigate it. Malawi signed the 2016 Political declaration of the high-level meeting of the United Nations General Assembly on antimicrobial resistance and endorsed the Global Action Plan on AMR. A national action plan (NAP) on AMR (Antimicrobial resistance strategy 2017–2022) was also published by Malawi in 2017. The NAP comprises a comprehensive operational plan, cost analysis, and monitoring and evaluation (M&E) structure in addition to including a One Health strategy to combating AMR and defining specific roles for relevant government ministries and implementation partners.

This policy brief from the One Health Trust and WHO assesses the present state of the Malawi national action plan on AMR implementation, identifies important gaps, and highlights findings to speed up future progress in the human health sector.

Find the brief here.